CLINICAL_TRIALS
trial_result
· 2014-02-20
Clinical Trial Update: A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab [Phase 2]
Summary
Phase 2 crossover trial evaluated the safety and tolerability of two formulations of adalimumab in rheumatoid arthritis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-02-20